Gene & Cell Therapies in Oncoimmunology
Reaseracher Group ahead
Monica Rinaldi
- 06 45488 219 (office)
- 06 45488 249 ( Iurescia/Fioretti )
- monica.rinaldi@ift.cnr.it
Istituto
Istituto di Farmacologia Traslazionale
Via Fosso del Cavaliere, 100 – Area di Ricerca Roma2 Tor Vergata
http://www.ift.cnr.it
Membri del Laboratorio
Dr. Sandra Iurescia (ricercatore III livello) sandra.iurescia@ift.cnr.it
Dr. Daniela Fioretti (ricercatore III livello) daniela.fioretti@ift.cnr.it
Dr. Antonella Lisi (Collaboratrice, ricercatore III livello) antonella.lisi@ift.cnr.it
Dr. Mario Ledda (Collaboratore, ricercatore III livello) mario.ledda@ift.cnr.it
Attività
- Nucleic acid-based therapeutics for targeted cancer immunotherapy
- Innate immune-enhancement strategy in oncoimmunology
- Biomaterials and novel devices in nano-oncology
- Innate immune response
- In vivo models of tissue damage from inflammation to remodelling/maturation
Strumenti / Tecnologie
- Molecular and Cellular Biology
- Development of multigenic plasmid vectors (DNA vaccine formulations
- Naked in vivo gene transfer trough electroporation technology
- In vitro/in vivo models
- Preclinical studies
- Gene expression (Real Time PCR)
- Protein analysis (ELISA test, Western Blotting)
- Bioinformatics
- Biocompatibility assessment
- Flow cytometry instrument; confocal microscope